These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 17821946

  • 21. [Diagnostic and prognostic value of B-type natriuretic peptides in heart failure or signs of heart failure].
    Rutten JH, Boomsma F, Van den Meiracker AH.
    Ned Tijdschr Geneeskd; 2007 Nov 17; 151(46):2553-7. PubMed ID: 18074722
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Comparison between analytical performances of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP.
    Prontera C, Zucchelli GC, Vittorini S, Storti S, Emdin M, Clerico A.
    Clin Chim Acta; 2009 Feb 17; 400(1-2):70-3. PubMed ID: 18992732
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A clinician's experience of using the Cardiac Reader NT-proBNP point-of-care assay in a clinical setting.
    Alehagen U, Janzon M.
    Eur J Heart Fail; 2008 Mar 17; 10(3):260-6. PubMed ID: 18304871
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [NT-proBNP in practice: from chemistry to medicine].
    Jourdain P, Lefèvre G, Oddoze C, Sapin V, Dievart F, Jondeau G, Meune C, Galinier M.
    Ann Biol Clin (Paris); 2009 Mar 17; 67(3):255-71. PubMed ID: 19411228
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Development and Evaluation of Up-Converting Phosphor Technology-Based Lateral Flow Assay for Quantitative Detection of NT-proBNP in Blood.
    Yang X, Liu L, Hao Q, Zou D, Zhang X, Zhang L, Li H, Qiao Y, Zhao H, Zhou L.
    PLoS One; 2017 Mar 17; 12(2):e0171376. PubMed ID: 28151978
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. An equation to explain variations in blood NT-proBNP in ambulatory cardiac subjects.
    Suwanugsorn S, Yipintsoi T, Geater AF, Jintapakorn W, Phromminthikul A.
    J Med Assoc Thai; 2009 Jan 17; 92(1):1-7. PubMed ID: 19260235
    [Abstract] [Full Text] [Related]

  • 35. Comparing serum and pleural fluid pro-brain natriuretic peptide (NT-proBNP) levels with pleural-to-serum albumin gradient for the identification of cardiac effusions misclassified by Light's criteria.
    Porcel JM, Chorda J, Cao G, Esquerda A, Ruiz-González A, Vives M.
    Respirology; 2007 Sep 17; 12(5):654-9. PubMed ID: 17875051
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M, Bozkurt A, Yildiray-Sahin D, Unal I, Acartürk E.
    Cardiol J; 2009 Sep 17; 16(1):43-9. PubMed ID: 19130415
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Importance and interpretation of intermediate (gray zone) amino-terminal pro-B-type natriuretic peptide concentrations.
    van Kimmenade RR, Pinto YM, Januzzi JL.
    Am J Cardiol; 2008 Feb 04; 101(3A):39-42. PubMed ID: 18243857
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.